chenodeoxycholic acid has been researched along with pirinixic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gonzalez, FJ; Sinal, CJ; Yoon, M | 1 |
Barbier, O; Bélanger, J; Caron, P; Grepper, S; Inaba, TT; Kaeding, J; Monté, D; Trottier, J; Verreault, M | 1 |
He, JG; Lu, XH; Lv, GP; Si, SY; Zhang, H; Zhao, BH; Zheng, ZH | 1 |
4 other study(ies) available for chenodeoxycholic acid and pirinixic acid
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids.
Topics: Animals; Bile Acids and Salts; Cell Line; Chenodeoxycholic Acid; Cholic Acid; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gastrointestinal Agents; Gene Expression Regulation; Ligands; Mice; Mice, Transgenic; Mutagens; Oxygen; Plasmids; Protein Biosynthesis; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transcriptional Activation; Transfection | 2001 |
Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.
Topics: Adult; Cell Line; Chenodeoxycholic Acid; Clofibric Acid; DNA-Binding Proteins; Female; Glucuronosyltransferase; Hepatocytes; Humans; Liver; Male; Microbodies; Microsomes, Liver; Middle Aged; PPAR alpha; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2006 |
Impacts of different promoters on the mammalian one-hybrid assay for detecting nuclear receptor agonists.
Topics: Animals; Bezafibrate; Cells, Cultured; Chenodeoxycholic Acid; Drug Discovery; Genetic Vectors; HeLa Cells; High-Throughput Screening Assays; Humans; Hydrocarbons, Fluorinated; Ligands; Mice; NIH 3T3 Cells; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Promoter Regions, Genetic; Pyrimidines; Rosiglitazone; Sensitivity and Specificity; Structure-Activity Relationship; Sulfonamides; Thiazolidinediones; Two-Hybrid System Techniques | 2010 |